Company Encyclopedia
View More
name
Mustang Bio
MBIO.US
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
1.911 T
MBIO.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Mustang Bio Inc. Announces Date for Upcoming Annual Stockholder Meeting

    Mustang Bio Inc. will hold its virtual Annual Meeting of Stockholders on December 22, 2025, where stockholders will vote on the election of seven directors for a one-year term.

    Reuters·
    US
    MBIO
    +2.83%
    Reuters·
    US
    MBIO
    +2.83%

    Mustang Bio | 10-Q: FY2025 Q3 Revenue: USD 0

    LB filings·
    US
    MBIO
    +2.83%
    LB filings·
    US
    MBIO
    +2.83%

    Mustang Energy starts drilling at Surprise Creek Uranium-Copper Project in Saskatchewan. Commencement announced on Oct 14, 2025.

    A drilling program has commenced at the Surprise Creek Uranium-Copper Project by Mustang Energy Corp. based in Vancouver, British Columbia. The company, identified as CSE: MEC, OTC:MECPF, FRA:92T, has started its first diamond-drilling initiative at the project situated near Uranium City, Saskatchewan. This project is positioned northwest of the Athabasca Basin.

    Unusual Whales·
    US
    MBIO
    +2.83%
    Unusual Whales·
    US
    MBIO
    +2.83%

    Mustang Bio | 10-Q: FY2025 Q2 EPS: USD -0.19

    LB filings·
    US
    MBIO
    +2.83%
    LB filings·
    US
    MBIO
    +2.83%

    U.S. stock market update: Mustang Bio up 11.81%

    Mustang Bio rose 11.81%; Gilead Sciences rose 8.65%, with a trading volume of USD 482 million; Fortress Biotech fell 1.61%, with a trading volume of USD 269 million; Natera rose 14.49%, with a trading volume of USD 210 million; AbbVie fell 0.77%, with a market capitalization of USD 348.5 billion

    Tracking Unusual Activity·
    US
    MBIO
    +2.83%
    Tracking Unusual Activity·
    US
    MBIO
    +2.83%
    © 2025 Longbridge｜Disclaimer